
Colgate-Palmolive Company (CL)
$
84.29
+0.15 (0.18%)
Key metrics
Financial statements
Free cash flow per share
4.5160
Market cap
67.6 Billion
Price to sales ratio
3.3148
Debt to equity
147.9259
Current ratio
0.9953
Income quality
1.8834
Average inventory
2.1 Billion
ROE
4.3159
Technology
Technology – consumer electronics
Largecap
With a market cap of 121,78 bil stock is ranked 1
Low risk
ISS score of this stock is ranked 1
Company description
Profile
Colgate-Palmolive Company, along with its subsidiaries, manufactures and sells consumer products on a global scale, operating through two distinct segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care segment offers a diverse range of products, including toothpaste, toothbrushes, mouthwash, various types of soaps, shower gels, shampoos, conditioners, deodorants, antiperspirants, and skin health products, as well as household cleaning items such as dishwashing detergents and fabric conditioners. This segment, which also includes pharmaceutical products aimed at dentists and other oral health professionals, markets its offerings under well-known brands like Colgate, Darlie, elmex, and Palmolive, reaching a wide audience through traditional and eCommerce retailers, wholesalers, and distributors. The operating expenses amount to $7,903,000,000.00 encompassing various operational costs incurred, alongside reported selling, general, and administrative expenses of $7,903,000,000.00 indicating its operational overhead costs. The company incurred an income tax expense of $798,000,000.00 reflecting its tax obligations. Additionally, the total costs and expenses for the company stand at $16,034,000,000.00 illustrating its overall spending, while the gross profit ratio is $0.60 which reflects the efficiency of the company's production and sales operations. In the Pet Nutrition segment, the company provides essential pet nutrition products under the Hill's Science Diet brand and therapeutic options for managing health conditions in pets through the Hill's Prescription Diet brand, with sales facilitated via pet supply retailers, veterinarians, and eCommerce platforms. In terms of market positioning, the stock is reasonably priced at $81.17 appealing to a broad range of investors. The stock has a high average trading volume of 6,795,269.00 indicating strong liquidity, which is an attractive factor for potential buyers. With a large market capitalization of $67,562,483,280.00 the company is a dominant player in the consumer goods sector. It is a key player in the Household & Personal Products industry, contributing significantly to the overall market landscape and driving innovation and growth within its Consumer Defensive sector.
Investing in Colgate-Palmolive Company (CL) depends on multiple factors, including revenue growth, profit margins, debt-to-equity ratio, earnings per share, and return on equity. Analysts have rated it as B+, with a Bearish outlook. Always conduct your own research before investing.
Analysts predict Colgate-Palmolive Company stock to fluctuate between $74.55 (low) and $99.33 (high) in the next 365 days, reflecting market expectations and potential volatility.
As of 2026-03-27, Colgate-Palmolive Company's market cap is $67,562,483,280, based on 801,548,028 outstanding shares.
Compared to WAL-MART STORES INC, Colgate-Palmolive Company has a Lower Market-Cap, indicating a difference in performance.
Colgate-Palmolive Company pays dividends. The current dividend yield is 2.48%, with a payout of $0.53 per share.
To buy Colgate-Palmolive Company (CL) stock: Open a brokerage account (e.g., Robinhood, TD Ameritrade, E-Trade). Search for CL. Place an order (Market, Limit, etc.).
The best time to invest depends on market trends and technical indicators, which show a Bearish trend based on economic conditions and company performance.
Colgate-Palmolive Company's last stock split was 2:1 on 2013-05-16.
Revenue: $20,382,000,000 | EPS: $2.64 | Growth: -25.21%.
Visit https://www.colgatepalmolive.com/investor-relations for detailed financial reports.
You can explore historical data from here
All-time high: $109.30 (2024-09-05) | All-time low: $67.62 (2023-10-06).
Key trends include market demand, economic conditions, interest rates, and industry competition, which influence the stock's performance.
News

reuters.com
A federal judge on Friday said Colgate-Palmolive must face two lawsuits claiming its packaging for mouth rinse misleads parents into believing children under 6 can use the products safely. The judge dismissed a similar lawsuit concerning Colgate toothpaste.

zacks.com
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

zacks.com
IVT, CL and TEL stand out as dividend growers, boosting payouts as inflation, Fed pause and Middle East tensions rattle markets.

businesswire.com
NEW YORK--(BUSINESS WIRE)--The Board of Directors of Colgate-Palmolive Company (NYSE:CL) today announced an increase in the quarterly common stock cash dividend to $0.53 up from $0.52 per share. The increase will be effective in the second quarter, 2026. The Board declared that the second quarter dividend is to be paid on May 15, 2026, to shareholders of record on April 20, 2026. On an annualized basis, the new dividend rate is $2.12 versus $2.08 per share previously. The Company has paid unint.

seekingalpha.com
Colgate-Palmolive Company (CL) Presents at UBS Global Consumer and Retail Conference Transcript

zacks.com
CL bets on science-led innovation, Colgate Total relaunch and AI-driven marketing to revive demand and boost premium growth across oral care and pet nutrition.

zacks.com
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

seekingalpha.com
Colgate-Palmolive (CL) is set to announce its 63rd consecutive annual dividend increase, with a predicted 2.9–4.8% boost to an annualized $2.14–$2.18. CL's recent restructuring has driven double-digit sales growth in select regions and 11% EPS growth in 2024, but future growth is expected to moderate. Dividend growth at CL is projected to remain in the low-to-mid single digits, reflecting its mature business and steady, reliable payout history.

zacks.com
CL and PG stack up on growth, margins and valuation as estimates, pricing power and category focus shape their outlooks.

zacks.com
NTLA, CL and GTY are in focus as Zacks highlights strong 12-week gains and post-upgrade rallies across its Focus List and model portfolios.
See all news